EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Stock Forecast for 2023 - 2025 - 2030

Updated on 04/24/2024

Stock Rating
17
Price Target
₺53.50
Consensus
Neutral
Upside
7.73%
Analysts
0
Stock Rating
17
Upside
7.73%
Analysts
0
Price Target
₺53.50

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Stock Forecast and Price Target

The average target price for EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s stock set by renowned analysts in recent months is ₺53.50, representing a potential upside of approximately 7.73% from its last closing price if met by 2025. This estimation is based on a high estimate of ₺53.50 and a low estimate of ₺53.50. Even if not interested in ECILC stock, you may want to be aware of its competitors.

₺53.50

7.73% Upside

Hold
Hold

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Fair Value Forecast for 2023 - 2025 - 2030

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s Price has seen growth In the last year, going from ₺-0.00 to ₺0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach ₺0.00 – an increase of 100.00%. For the next six years, the forecast is forFair Value to grow by 100.00%.

2025 Fair Value Forecast
₺0.00
2026 Fair Value Forecast
₺0.00
2027 Fair Value Forecast
₺0.00
2028 Fair Value Forecast
₺0.00
2029 Fair Value Forecast
₺0.00
2030 Fair Value Forecast
₺0.00

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Revenue Forecast for 2023 - 2025 - 2030

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s Revenue has seen growth In the last two years, going from ₺909.13M to ₺1.83B – a gain of 101.36% According to 0 analysts, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s Revenue will fall by 32.35% in the next year, reaching ₺1.24B. Professionals believe that By 2030, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s Revenue will fall to ₺1.34B – a 26.58% decrease from its current value.

2023 Rev Forecast
₺1.24B
2024 Rev Forecast
₺1.20B
2025 Rev Forecast
₺1.24B
2026 Rev Forecast
₺1.44B
2027 Rev Forecast
₺1.37B
2028 Rev Forecast
₺1.32B
2029 Rev Forecast
₺1.30B
2030 Rev Forecast
₺1.34B

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, Dividend per Share for EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. has grown by 100.00%, going from ₺0.00 to ₺0.41. In the following year, 0 experts forecast that EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s Dividend per Share will decrease by 52.85%, to ₺0.19. In 2030, professionals predict that EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s Dividend per Share will decrease by 35.40%, to ₺0.26.

2023 DPS Forecast
₺0.19
2024 DPS Forecast
₺0.18
2025 DPS Forecast
₺0.24
2026 DPS Forecast
₺0.31
2027 DPS Forecast
₺0.27
2028 DPS Forecast
₺0.24
2029 DPS Forecast
₺0.24
2030 DPS Forecast
₺0.26

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Free Cash Flow Forecast for 2023 - 2025 - 2030

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s EBITDA has increased by 75.57%, going from ₺132.61M to ₺232.82M. For the following year, the 0 analysts predict that EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s EBITDA will drop by 26.87%, reaching ₺170.26M. In 2030, the professionals' prediction is that ECILC's EBITDA will decrease by 23.30%, reaching ₺178.57M.

2023 EBITDA Forecast
₺0.17B
2024 EBITDA Forecast
₺0.18B
2025 EBITDA Forecast
₺0.16B
2026 EBITDA Forecast
₺0.19B
2027 EBITDA Forecast
₺0.18B
2028 EBITDA Forecast
₺0.18B
2029 EBITDA Forecast
₺0.18B
2030 EBITDA Forecast
₺0.18B

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. EBIT Forecast for 2023 - 2025 - 2030

In the last two years, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s EBIT has grown, increasing from ₺123.27M to ₺190.45M – an increase of 54.50%. In the following year, the 0 analysts surveyed believe that EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s EBIT will decrease by 22.73%, reaching ₺147.17M. According to professionals, by 2030, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s EBIT will have decreased by 20.34%, falling down to ₺151.72M.

2023 EBIT Forecast
₺0.15B
2024 EBIT Forecast
₺0.15B
2025 EBIT Forecast
₺0.14B
2026 EBIT Forecast
₺0.16B
2027 EBIT Forecast
₺0.15B
2028 EBIT Forecast
₺0.15B
2029 EBIT Forecast
₺0.15B
2030 EBIT Forecast
₺0.15B

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. EPS Price Prediction Forecast for 2023 - 2025 - 2030

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.'s EPS has seen growth In the last year, going from ₺-0.00 to ₺0.00 – a gain of 100.00% In the next year, analysts believe that EPS will reach ₺0.00 – an increase of 100.00%. For the next six years, the forecast is forEPS to grow by 100.00%.

2025 EPS Forecast
₺0.00
2026 EPS Forecast
₺0.00
2027 EPS Forecast
₺0.00
2028 EPS Forecast
₺0.00
2029 EPS Forecast
₺0.00
2030 EPS Forecast
₺0.00